#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colon cancer MELAS syndrome Castleman's disease Skin angiosarcoma Acute respiratory distress syndrome Bladder cancer Rhabdomyosarcoma Cutaneous T-cell lymphoma refractory Activated PI3 kinase delta syndrome Multiple system atrophy Anal cancer Multifocal motor neuropathy Malignant peritoneal neoplasm Liver transplant rejection Optic glioma More trials…

    Learn about Rare Diseases

    VEXAS syndrome Rhabdoid tumour – Treatment Angiosarcoma metastatic – Basic Information VEXAS syndrome – Life with Disease Krabbe’s disease – Basic Information Mast cell activation syndrome – Basic Information Malignant fibrous histiocytoma – Basic Information Pleomorphic leiomyosarcoma – Life with Disease Splenic marginal zone lymphoma – Treatment Haemophilia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amantadine Hydrochloride Selumetinib Pimavanserin Tartrate Omx-0407 Siltuximab Lurasidone Faricimab Satoreotide Tetraxetan Tolinapant Lactate Nortriptyline RLY-2608 Alendronic Acid Amniotic Membrane, Human Ptg-Carcik-Cd19 Magnesium Oxybate Volrustomig Almagate Pamidronate Disodium Cefazolin Sodium Ale.c04 More therapies…

    Learn about Your Condition

    Psoriatic arthropathy Mixed-type liposarcoma Hepatic angiosarcoma Bacterial infection Seasonal allergy Petit mal epilepsy Erythema migrans Arthralgia Peritoneal sarcoma Hypereosinophilic syndrome Encephalopathy neonatal Hypertension Osteopenia Thrombocytosis Tumour of ampulla of Vater More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Olaparib for Patients with Recurrent Ovarian Cancer Without BRCA Gene Mutations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Olaparib
    Italy

  • Study of Lisaftoclax and Acalabrutinib for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Chlorambucil
    • Lisaftoclax
    • Cyclophosphamide Monohydrate
    Bulgaria Czechia Spain

  • Study on Esketamine and Diphenhydramine for Treating Depression and Negative Symptoms in Schizophrenia Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Negative symptoms in schizophrenia
    • Schizoaffective disorder depressive type
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Diphenhydramine Hydrochloride
    Austria

  • Study on Deferoxamine to Improve Hypoxia Response in Type 1 Diabetes Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypoxia
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Deferoxamine Mesilate
    Sweden

  • Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

    Recruiting

    4 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Vigabatrin
    • Sirolimus
    Poland

  • Study on ICEF15 for Treating Fecal Incontinence in Patients with Anal Sphincter Dysfunction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Anal incontinence
    Investigated Drugs:
    • ICEF15
    • Placebo
    Austria Bulgaria Czechia France Germany Italy +4
Previous Page
1 … 260 261 262 263 264 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!